Publications

Connors, JJ, D Sacks, AJ Furlan, WR Selman, RA Hauser, and . 2009. “Training, Competency, and Credentialing Standards for Diagnostic Cervicocerebral Angiography, Carotid Stenting, and Cerebrovascular Intervention: A Joint Statement from the American Academy of Neurology, . ”. J Vasc Interv Radiol.

Hauser, RA, KE Lyons, T McClain, S Carter, and D Perlmutter. 2009. “Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson’s Disease”. Mov Disord.

Hauser, RA, MF Lew, HI Hurtig, WG Ondo, J Wojcieszek, and CJ Fitzer-Attas. 2009. “TEMPO Open-Label Study Group. Long-Term Outcome of Early versus Delayed Rasagiline Treatment in Early Parkinson’s Disease.”. Mov Disord.

Hauser, RA, M Panisset, G Abbruzzese, L Mancione, N Dronamraju, and A Kakarieka. 2009. “Double-Blind Trial of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa in Early Parkinson’s Disease”. Mov Disord.

Zesiewicz, TA, RA Hauser, A Freeman, KL Sullivan, AM Miller, and T Halim. 2009. “Fentanyl-Induced Bradykinesia and Rigidity After Deep Brain Stimulation in a Patient With Parkinson Disease”. Clin Neuropharmacol.

Hauser, RA. 2009. “Levodopa: Past, Present, and Future”. Eur Neurol.

Simuni, T, KE Lyons, R Pahwa, RA Hauser, C Comella, L Elmer, and D Weintraub. 2009. “Treatment of Early Parkinson’s Disease. Part 1.”. Eur Neurol.

Kordower, JH, Y Chu, RA Hauser, CW Olanow, and TB Freeman. 2008. “Transplanted Dopaminergic Neurons Develop PD Pathologic Changes: A Second Case Report”. Mov Disord.

Olanow, CW, RA Hauser, J Jankovic, W Langston, A Lang, W Poewe, E Tolosa, et al. 2008. “A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline As a Disease Modifying Therapy in Parkinson’s Disease (the ADAGIO Study): Rationale, Design, and Baseline Characteristics.”. Mov Disord.

Hauser, RA, LM Shulman, JM Trugman, JW Roberts, A Mori, R Ballerini, and NM Sussman. 2008. “Study of Istradefylline in Patients With Parkinson’s Disease on Levodopa With Motor Fluctuations.”. Mov Disord.